MDxHealth director reports option holdings on Form 3

MDxHealth SA director Koen Hoffman filed an initial statement of beneficial ownership, detailing his existing share option holdings.

Rhea-AI Filing Summary

MDxHealth SA director Koen Hoffman filed an initial statement of beneficial ownership, detailing his existing share option holdings. He reports options over 1,000 and 2,000 ordinary shares at exercise prices of 49.70 Euros and 12.80 Euros, granted in 2018 and 2019 and already fully vested. He also reports options over 30,000 and 10,000 ordinary shares at exercise prices of $2.62 and $2.18, granted in 2024 and 2025. Part of these options are held indirectly through Ahok BV, where he owns 53.33%, and he disclaims beneficial ownership beyond his pecuniary interest.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Hoffman Koen

Role Director

Type	Security	Shares	Price	Value
holding	Share Option	--	--	--
holding	Share Option	--	--	--
holding	Share Option	--	--	--
holding	Share Option	--	--	--

Holdings After Transaction: Share Option — 3,000 contracts (Direct); Share Option — 40,000 contracts (Indirect, By Ahok BV)

Footnotes (5)

1. F1. Represents options to purchase 1,000 ordinary shares of the Issuer at a price per share of 49.70 Euros granted on June 1, 2018 which vested in full on the date of the annual general shareholders' meeting that took place in the calendar year following the calendar year in which the options were granted.
2. F2. Represents options to purchase 2,000 ordinary shares of the Issuer at a price per share of 12.80 Euros granted on July 1, 2019 which vested in full on the date of the annual general shareholders' meeting that took place in the calendar year following the calendar year in which the options were granted.
3. F3. Represents options to purchase 30,000 ordinary shares of the Issuer at a price per share of $2.62 granted on June 22, 2024 which vested in full on the date of the annual general shareholders' meeting that took place in the calendar year following the calendar year in which the options were granted.
4. F4. Shares held by Ahok BV may be deemed to be beneficially owned by the Reporting Person as the owner of 53.33% of Ahok BV. The Reporting Person disclaims beneficial ownership of the securities held by Ahok BV other than to the extent that he may have a pecuniary interest therein.
5. F5. Represents options to purchase 10,000 ordinary shares of the Issuer at a price per share of $2.18 granted on June 27, 2025 which vest in full on the date of the annual general shareholders' meeting that takes place in the calendar year following the calendar year in which the options were granted.

Key Figures

Direct options 2018 grant: 1,000 ordinary shares at 49.70 Euros Direct options 2019 grant: 2,000 ordinary shares at 12.80 Euros Indirect options 2024 grant: 30,000 ordinary shares at $2.62 +4 more

7 metrics

Direct options 2018 grant 1,000 ordinary shares at 49.70 Euros Options granted June 1, 2018, fully vested

Direct options 2019 grant 2,000 ordinary shares at 12.80 Euros Options granted July 1, 2019, fully vested

Indirect options 2024 grant 30,000 ordinary shares at $2.62 Options granted June 22, 2024, held via Ahok BV

Indirect options 2025 grant 10,000 ordinary shares at $2.18 Options granted June 27, 2025, held via Ahok BV

Ahok BV ownership 53.33% interest Percentage of Ahok BV owned by Koen Hoffman

Earliest option expiration June 1, 2028 Expiration date for 1,000-share option grant

Latest option expiration June 27, 2035 Expiration date for 10,000-share option grant

Key Terms

Share Option, Ordinary Shares, beneficially owned, pecuniary interest

4 terms

Share Option financial

"Represents options to purchase 1,000 ordinary shares of the Issuer"

Ordinary Shares financial

"Represents options to purchase 30,000 ordinary shares of the Issuer"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

beneficially owned financial

"Shares held by Ahok BV may be deemed to be beneficially owned by the Reporting Person"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

pecuniary interest financial

"disclaims beneficial ownership of the securities held by Ahok BV other than to the extent that he may have a pecuniary interest"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 filing by Koen Hoffman for MDXH report?

It reports Koen Hoffman’s existing share option holdings in MDxHealth SA. The filing lists four option grants over ordinary shares, including exercise prices, grant dates, vesting details, expirations, and whether they are held directly or indirectly through Ahok BV.

How many MDxHealth (MDXH) shares are covered by Koen Hoffman’s options?

The filing shows options over 1,000 and 2,000 ordinary shares held directly, plus 30,000 and 10,000 ordinary shares held indirectly via Ahok BV. In total, 43,000 ordinary shares are subject to the reported option awards, according to the disclosed footnotes and summaries.

What are the exercise prices of Koen Hoffman’s MDXH share options?

Two grants have exercise prices of 49.70 Euros and 12.80 Euros per share from 2018 and 2019. Two later grants have exercise prices of $2.62 and $2.18 per share from 2024 and 2025, reflecting different award periods and currency denominations.

How are Ahok BV and Koen Hoffman related in the MDXH Form 3?

Some options are held indirectly through Ahok BV, which may be deemed beneficially owned by Koen Hoffman as owner of 53.33% of Ahok BV. He expressly disclaims beneficial ownership of securities held by Ahok BV except to the extent of his pecuniary interest.

Do Koen Hoffman’s MDXH options reported on Form 3 involve recent buying or selling?

No, the Form 3 lists existing option holdings rather than recent trades. Transactions are classified as holdings with unknown transaction codes, and the transaction summary shows no buy, sell, or exercise activity associated with these reported derivative positions.

When do Koen Hoffman’s MDXH share options expire?

The options expire on June 1, 2028, July 1, 2029, June 22, 2034, and June 27, 2035. These staggered expiration dates correspond to the different grant years disclosed, providing a long-dated schedule for potential exercise of the option awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/09/2026 - 04:04 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Hoffman Koen

(Last) (First) (Middle)

CAP BUSINESS CENTER

ZONE INDUSTRIELLE DES HAUTS-SARTS

(Street)

HERSTAL BELGIUM 4040

(City) (State) (Zip)

BELGIUM

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
MDxHealth SA [ MDXH ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Option	(1)	06/01/2028	Ordinary Shares	1,000	(1)	D
Share Option	(2)	07/01/2029	Ordinary Shares	2,000	(2)	D
Share Option	(3)	06/22/2034	Ordinary Shares	30,000	$2.62	I	By Ahok BV(4)
Share Option	(5)	06/27/2035	Ordinary Shares	10,000	$2.18	I	By Ahok BV(4)

Explanation of Responses:

1. Represents options to purchase 1,000 ordinary shares of the Issuer at a price per share of 49.70 Euros granted on June 1, 2018 which vested in full on the date of the annual general shareholders' meeting that took place in the calendar year following the calendar year in which the options were granted.

2. Represents options to purchase 2,000 ordinary shares of the Issuer at a price per share of 12.80 Euros granted on July 1, 2019 which vested in full on the date of the annual general shareholders' meeting that took place in the calendar year following the calendar year in which the options were granted.

3. Represents options to purchase 30,000 ordinary shares of the Issuer at a price per share of $2.62 granted on June 22, 2024 which vested in full on the date of the annual general shareholders' meeting that took place in the calendar year following the calendar year in which the options were granted.

4. Shares held by Ahok BV may be deemed to be beneficially owned by the Reporting Person as the owner of 53.33% of Ahok BV. The Reporting Person disclaims beneficial ownership of the securities held by Ahok BV other than to the extent that he may have a pecuniary interest therein.

5. Represents options to purchase 10,000 ordinary shares of the Issuer at a price per share of $2.18 granted on June 27, 2025 which vest in full on the date of the annual general shareholders' meeting that takes place in the calendar year following the calendar year in which the options were granted.

	/s/ Mark Busch, as attorney-in-fact for Koen Hoffman	04/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)